Login
Willkomen zurück, bitte gebe deine Zugangsdaten ein!
E-Mail:
Passwort:
Passwort vergessen
Anmelden
Konto erstellen
Anmeldung erfolgt in Kürze...
query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://www.finanzen.at/nachrichten/aktien/nestle-to-sell-mainstream-vms-business-to-yellow-wood-for-$1-bln-1036513453
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
Nestle To Sell Mainstream VMS Business To Yellow Wood For $1 Bln | 02.09.26 | finanzen.at
(RTTNews) - Nestlé (NSTR.L, NESN.SW) on Tuesday said it has agreed to divest its mainstream Vitamins, Minerals and Supplements (VMS) business, the...
Ähnliche Seiten
Nestle To Sell Mainstream VMS Business To Yellow Wood For $1 Bln | 02.09.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/nestle-to-sell-mainstream-vms-business-to-yellow-wood-for-$1-bln-1036513453
Swiss food giant Nestle sells supplements business to US firm for $1 billion
https://www.thelocal.ch/20260902/swiss-food-giant-nestle-sells-supplements-business-to-us-firm-for-1-billion
Press Release: Nestle: Nestlé reaches agreement to divest its mainstream vitamins, minerals and supplements business | 01.09.26 | finanzen.at
https://www.finanzen.at/nachrichten/aktien/press-release-nestle-nestle-reaches-agreement-to-divest-its-mainstream-vitamins-minerals-and-supplements-business-1036512396
Nestle to divest mainstream supplements business for $1 billion - The Economic Times
https://economictimes.indiatimes.com/industry/cons-products/nestle-to-divest-mainstream-supplements-business-for-1-billion/articleshow/133689701.cms
Press Release: Nestle: Nestlé reaches agreement to divest its mainstream vitamins, minerals and supplements business | 01.09.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/press-release-nestle-nestle-reaches-agreement-to-divest-its-mainstream-vitamins-minerals-and-supplements-business-1036512394
Edgewise Therapeutics To Sell Muscular Dystrophy Business & Sevasemten For Up To $2.65 Bln | 01.06.26 | finanzen.ch
https://www.finanzen.ch/nachrichten/aktien/edgewise-therapeutics-to-sell-muscular-dystrophy-business-&-sevasemten-for-up-to-$2-65-bln-1036213040
Please enable JavaScript to continue using this application.